메뉴 건너뛰기




Volumn 39, Issue SUPPL. 1, 2011, Pages

A dose-finding study of C. E. R. A. (Continuous Erythropoietin Receptor Activator) in renal anemia patients on hemodialysis - A randomized double-blind comparative study

(24)  Kinugasa, Eriko a   Yumita, Shigeru b   Sato, Takashi c,d   Kurosawa, Akira c   Kitaoka, Tateki e   Sugimoto, Hisayuki f   Nakayama, Fumiyoshi g   Miyazaki, Shigeru h   Muto, Hisao i   Kanno, Yutaka j,k   Kasuga, Hirotake l,m   Seno, Hachiro n,o   Tsuruta, Yoshinari p   Kakiya, Ryusuke q,r   Motomiya, Yoshihiro s   Moriishi, Misaki t   Minakuchi, Jun u   Takeda, Kazuhito v   Shiroozu, Akiyo w   Hirakawa, Makoto x,y   more..


Author keywords

C. E. R. A.; CERA; Double blind study; Epoetin beta pegol (genetical recombination); Erythropoietin; ESA; Hemodialysis; Optimal dose; Polyethylene glycol (PEG); Renal anemia; Ro50 3821

Indexed keywords

HEMOGLOBIN; PEGINESATIDE; RECOMBINANT ERYTHROPOIETIN;

EID: 79958238866     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (5)
  • 1
    • 35348839061 scopus 로고    scopus 로고
    • Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: A randomized non-inferiority trial (MAXIMA)
    • Levin NW, Fishbane S, Cañedo FY Zeig S, Nassar GM, Moran JE, et al. Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis : a randomized non-inferiority trial (MAXIMA). Lancet 2007 ; 370 : 1415-21.
    • (2007) Lancet , vol.370 , pp. 1415-1421
    • Levin, N.W.1    Fishbane, S.2    Cañedo, F.Y.3    Zeig, S.4    Nassar, G.M.5    Moran, J.E.6
  • 3
    • 79958218832 scopus 로고    scopus 로고
    • Japanese source
  • 4
    • 79958218524 scopus 로고    scopus 로고
    • Japanese source
  • 5
    • 79958216870 scopus 로고    scopus 로고
    • Japanese source


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.